Making The Most Of FDA’s Pre-Market Process: Insiders Share Tips
This article was originally published in The Gray Sheet
Executive Summary
In search of the latest insider tips on navigating FDA's pre-market review process, "The Gray Sheet" invited three experts to speak on the topic. They answered our questions during a panel discussion Oct. 24 at Windhover Information's 1In3 East meeting in Boston
You may also be interested in...
510(k) Sponsors Should Be Wary Of Informal Talk With FDA, Attorney Says
Informal communications via telephone or e-mail before or during a 510(k) submission can be an efficient approach for sponsors, but companies should be aware of the pitfalls, says Hogan & Hartson Partner and FDA device specialist John Smith
510(k) Sponsors Should Be Wary Of Informal Talk With FDA, Attorney Says
Informal communications via telephone or e-mail before or during a 510(k) submission can be an efficient approach for sponsors, but companies should be aware of the pitfalls, says Hogan & Hartson Partner and FDA device specialist John Smith
Cross-Center CDRH Matrix Goes Live After Six Months Of Ground Work
Recently appointed leaders of CDRH's new cross-center post-market safety "matrix" organization are officially on the job, beginning July 14, after six months of initial training and testing of the collaborative system